SOX4 and neoplasm: miR-22, miR-133a, and miR-223 act mainly as tumor suppressors by inhibiting cell proliferation, migration and invasion through the modulation of epithelial–mesenchymal transition (EMT)-associated programs and targets such as SOX4 and ARTN [24,25,26].